AfterPullback: Biotech Stocks

AfterPullback: Biotech Stocks

“AfterPullback: Biotech Stocks” delivers a comprehensive overview of leading U.S.-traded biotech companies, along with emerging and innovative firms that have recently entered the public market. Our selection spans a variety of sectors within biotech, including gene editing, diagnostics, pharmaceuticals, immunotherapy, cancer treatment, regenerative medicine, and bioinformatics.

6 Symbols in watchlist.

SymbolPriceChange %Market CapVolume
MRNA $33.32 -1.45% $14.18B 6,295,489
PACB $1.29 4.47% $384.48M 5,187,634
BNTX $113.82 0.99% $27.11B 257,262
FLGT $21.36 -1.75% $666.36M 112,824
CRSP $60.17 2.29% $5.21B 1,961,282
ILMN $100.68 0.59% $16.01B 624,731

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.